Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice
[Display omitted] Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of...
Gespeichert in:
| Veröffentlicht in: | Pharmacological research 2020-08, Vol.158, p.104878-104878, Article 104878 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 104878 |
|---|---|
| container_issue | |
| container_start_page | 104878 |
| container_title | Pharmacological research |
| container_volume | 158 |
| creator | Chiricozzi, Andrea Comberiati, Pasquale D’Auria, Enza Zuccotti, GianVincenzo Peroni, Diego G. |
| description | [Display omitted]
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations.
Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach. |
| doi_str_mv | 10.1016/j.phrs.2020.104878 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2404371220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661820311865</els_id><sourcerecordid>2404371220</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-d7fcaeef9e07f1a0e72bdf8924ba513e76141e249509e7cc9ec768490e9075a43</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwBxhQRpYU23HsGLGgii-pEks7W65zpq7SOtgOEv-eRCmMTHc6Pe8r3YPQNcFzggm_283bbYhziulwYJWoTtCUYMlzQip-OuysyDkn1QRdxLjDGEtG8DmaFJQRUeJiitYr3zqjm8z4kJzxMUHwro6Z9SFroXY6BWcynQYsqyHsdXLJxftstfXdxzbZrsmSa4-BoE3fApfozOomwtVxztD6-Wm1eM2X7y9vi8dlboqSp7wW1mgAKwELSzQGQTe1rSRlG12SAgQnjABlssQShDESjOAVkxgkFqVmxQzdjr1t8J8dxKT2LhpoGn0A30VFWW9AEEpxj9IRNcHHGMCqNri9Dt-KYDXoVDs16FSDTjXq7EM3x_5us4f6L_LrrwceRgD6L78cBBWNg4PpxQUwSdXe_df_AzhFh48</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404371220</pqid></control><display><type>article</type><title>Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Chiricozzi, Andrea ; Comberiati, Pasquale ; D’Auria, Enza ; Zuccotti, GianVincenzo ; Peroni, Diego G.</creator><creatorcontrib>Chiricozzi, Andrea ; Comberiati, Pasquale ; D’Auria, Enza ; Zuccotti, GianVincenzo ; Peroni, Diego G.</creatorcontrib><description>[Display omitted]
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations.
Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1016/j.phrs.2020.104878</identifier><identifier>PMID: 32417503</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Atopic dermatitis ; Children ; Corticophobia ; Corticosteroids ; Pediatric ; Side effects ; Topical therapy</subject><ispartof>Pharmacological research, 2020-08, Vol.158, p.104878-104878, Article 104878</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright © 2020 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-d7fcaeef9e07f1a0e72bdf8924ba513e76141e249509e7cc9ec768490e9075a43</citedby><cites>FETCH-LOGICAL-c356t-d7fcaeef9e07f1a0e72bdf8924ba513e76141e249509e7cc9ec768490e9075a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1043661820311865$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32417503$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiricozzi, Andrea</creatorcontrib><creatorcontrib>Comberiati, Pasquale</creatorcontrib><creatorcontrib>D’Auria, Enza</creatorcontrib><creatorcontrib>Zuccotti, GianVincenzo</creatorcontrib><creatorcontrib>Peroni, Diego G.</creatorcontrib><title>Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>[Display omitted]
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations.
Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.</description><subject>Atopic dermatitis</subject><subject>Children</subject><subject>Corticophobia</subject><subject>Corticosteroids</subject><subject>Pediatric</subject><subject>Side effects</subject><subject>Topical therapy</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EoqXwBxhQRpYU23HsGLGgii-pEks7W65zpq7SOtgOEv-eRCmMTHc6Pe8r3YPQNcFzggm_283bbYhziulwYJWoTtCUYMlzQip-OuysyDkn1QRdxLjDGEtG8DmaFJQRUeJiitYr3zqjm8z4kJzxMUHwro6Z9SFroXY6BWcynQYsqyHsdXLJxftstfXdxzbZrsmSa4-BoE3fApfozOomwtVxztD6-Wm1eM2X7y9vi8dlboqSp7wW1mgAKwELSzQGQTe1rSRlG12SAgQnjABlssQShDESjOAVkxgkFqVmxQzdjr1t8J8dxKT2LhpoGn0A30VFWW9AEEpxj9IRNcHHGMCqNri9Dt-KYDXoVDs16FSDTjXq7EM3x_5us4f6L_LrrwceRgD6L78cBBWNg4PpxQUwSdXe_df_AzhFh48</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Chiricozzi, Andrea</creator><creator>Comberiati, Pasquale</creator><creator>D’Auria, Enza</creator><creator>Zuccotti, GianVincenzo</creator><creator>Peroni, Diego G.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200801</creationdate><title>Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice</title><author>Chiricozzi, Andrea ; Comberiati, Pasquale ; D’Auria, Enza ; Zuccotti, GianVincenzo ; Peroni, Diego G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-d7fcaeef9e07f1a0e72bdf8924ba513e76141e249509e7cc9ec768490e9075a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Atopic dermatitis</topic><topic>Children</topic><topic>Corticophobia</topic><topic>Corticosteroids</topic><topic>Pediatric</topic><topic>Side effects</topic><topic>Topical therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiricozzi, Andrea</creatorcontrib><creatorcontrib>Comberiati, Pasquale</creatorcontrib><creatorcontrib>D’Auria, Enza</creatorcontrib><creatorcontrib>Zuccotti, GianVincenzo</creatorcontrib><creatorcontrib>Peroni, Diego G.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiricozzi, Andrea</au><au>Comberiati, Pasquale</au><au>D’Auria, Enza</au><au>Zuccotti, GianVincenzo</au><au>Peroni, Diego G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>158</volume><spage>104878</spage><epage>104878</epage><pages>104878-104878</pages><artnum>104878</artnum><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>[Display omitted]
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin disease, affecting up to 25% of children. Topical corticosteroids (TCS) are currently used as first-line antiinflammatory treatment for AD, due to their overall therapeutic efficacy, and the availability of different potency classes and a wide array of formulations.
Therapeutic efficacy of TCS depends upon selecting the appropriate vehicle and potency, and the frequency of application, also taking into account the duration of treatment and patient preferences. This article focuses on TCS benefits and potential risks and it provides practical tips to properly use these drugs in clinical practice, to make a patient-tailored treatment approach.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>32417503</pmid><doi>10.1016/j.phrs.2020.104878</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1043-6618 |
| ispartof | Pharmacological research, 2020-08, Vol.158, p.104878-104878, Article 104878 |
| issn | 1043-6618 1096-1186 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2404371220 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Atopic dermatitis Children Corticophobia Corticosteroids Pediatric Side effects Topical therapy |
| title | Topical corticosteroids for pediatric atopic dermatitis: Thoughtful tips for practice |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T07%3A44%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Topical%20corticosteroids%20for%20pediatric%20atopic%20dermatitis:%20Thoughtful%20tips%20for%20practice&rft.jtitle=Pharmacological%20research&rft.au=Chiricozzi,%20Andrea&rft.date=2020-08-01&rft.volume=158&rft.spage=104878&rft.epage=104878&rft.pages=104878-104878&rft.artnum=104878&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1016/j.phrs.2020.104878&rft_dat=%3Cproquest_cross%3E2404371220%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404371220&rft_id=info:pmid/32417503&rft_els_id=S1043661820311865&rfr_iscdi=true |